newsfilter
← Latest News
GlobeNewswire·

Profile of Entasis Therapeutics ETX0462 Candidate Published in the Journal Nature

WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the publication of